Tokyo -- Fujifilm Diosynth Biotechnologies is allocating manufacturing capacity at its Denmark facility to develop coronavirus treatments with the COVID-19 Therapeutics Accelerator led by the Bill and Melinda Gates Foundation.
Diosynth Biotechnologies is a subsidiary of Fujifilm Holdings, which also produces Avigan, the flu medication said to be effective in treating the novel coronavirus.
